Annals of Oncology 14:1689-1690, 2003
© 2003 European Society for Medical Oncology
Letters to the Editor |
Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin
Division of Medical Oncology A, Regina Elena Cancer Institute, Rome, Italy
*E-mail: pcarlini@iol.it
| The first 10% of the full text of this article appears below. |
A 37-year-old premenopausal woman with relapsed breast cancer (BC) in the right supraclavicular nodes, after failed treatment with the combination luteinizing hormone releasing hormone-a (LHRHa; triptorelin) plus tamoxifen, was started on triptorelin 3.75 mg every 28 days plus letrozole 2.5 mg daily. Approximately 6 months after starting this therapy, she complained of a daily scalp hair loss while
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Ferrero, G. Camerini, R. Seracchioli, N. Ragni, P.L. Venturini, and V. Remorgida Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis Hum. Reprod., September 2, 2009; (2009) dep302v1. [Abstract] [Full Text] [PDF] |
||||
